Current opinion in pharmacologyHumansBiological ProductsAnimalsInflammatory Bowel DiseasesGastrointestinal Microbiome
Targeting the unmet needs in IBD: Emerging therapies beyond biologics and small molecules.
Fabrizio Fanizzi, Laurent Peyrin-Biroulet, Silvio Danese, Ferdinando D'Amico
Published: 202510.1016/j.coph.2025.102577
Abstract
Despite progress with biologics and small molecules, a substantial proportion of patients with inflammatory bowel disease (IBD) continue to face unmet needs, including non-response, disease recurrence, and impaired quality of life. These limitations…
Preview only. Read the full abstract at the source